Biotech · Private company · Boston, MA, US
HilleVax, Inc.
SEC CIK 0001888012
Track this companyFree. Adds HilleVax, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- HIL-214Phase 3 · GastroenteritisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Serologic Assay Validation and Proficiency Testing of HIL-214 in AdultsPHASE2 · COMPLETED · started Aug 1, 2023ClinicalTrials.gov NCT05972733 · fetched Nov 12, 2026
- Safety and Immunogenicity of HIL-214 With Routine Pediatric VaccinesPHASE2_PHASE3 · COMPLETED · started Jun 10, 2023ClinicalTrials.gov NCT05836012 · fetched Nov 12, 2026
- Efficacy and Safety of Two Doses of HIL-214 in ChildrenPHASE2_PHASE3 · TERMINATED · started Apr 28, 2022ClinicalTrials.gov NCT05281094 · fetched Nov 12, 2026
SEC filings10
- 8-K · 8-KSEC EDGAR · filed Sep 17, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 6, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 6, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 4, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 25, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 8, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 8, 2025 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 28, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 28, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Dec 5, 2024 · fetched Nov 12, 2026